Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
HCW Biologics Inc. (HCWB) had Cash Flow from Financial Activities of $0.85M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$6.54M |
|
$1.98M |
|
$0.01M |
|
$6.53M |
|
$3.31M |
|
$3.24M |
|
$0.57M |
|
$3.80M |
|
$3.80M |
|
$3.47M |
|
$3.47M |
|
$3.47M |
|
$3.47M |
|
$3.24M |
|
$3.38M |
|
5.43M |
|
5.43M |
|
$0.37 |
|
$0.37 |
|
| Balance Sheet Financials | |
$1.72M |
|
$20.77M |
|
$25.62M |
|
$27.34M |
|
$19.96M |
|
-- |
|
$1.62M |
|
$21.58M |
|
$5.76M |
|
$5.76M |
|
$5.76M |
|
6.73M |
|
| Cash Flow Statement Financials | |
$-1.58M |
|
-- |
|
|
Cash Flow from Financial Activities |
$0.85M |
$1.95M |
|
$1.23M |
|
$-0.72M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.09 |
|
-- |
|
-- |
|
-- |
|
1.14 |
|
99.83% |
|
49.45% |
|
49.45% |
|
-- |
|
58.12% |
|
30.32% |
|
$-1.58M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
-- |
|
87.42 |
|
1.03 |
|
60.26% |
|
60.26% |
|
12.70% |
|
60.26% |
|
$0.86 |
|
$-0.29 |
|
$-0.29 |
|